Endoscopy Device Market Size, Share, Growth, and Industry Analysis, By Type (Rigid Endoscopes,Flexible Endoscopes), By Application (Hospital & Clinic,ASCs,Others), Regional Insights and Forecast to 2035

Endoscopy Device Market Overview

The global Endoscopy Device Market size is projected to grow from USD 8362.32 million in 2026 to USD 8847.34 million in 2027, reaching USD 14020.79 million by 2035, expanding at a CAGR of 5.8% during the forecast period.

The global endoscopy devices market reached an estimated size of USD 50.01 billion in 2024, marking a substantial baseline for global industry activities in endoscopic devices. In 2024, endoscopic procedures worldwide numbered about 191.1 million procedures, indicating a high utilization of endoscopy devices, with gastrointestinal endoscopy accounting for 69.8% of total procedures in that year. The increasing demand for minimally invasive diagnostic and surgical procedures, coupled with rising prevalence of chronic gastrointestinal, urological, respiratory, and other internal organ disorders, underlines the global reliance on endoscopy devices for both diagnostics and treatment.

In the United States, the endoscopy device demand is significant due to the high number of endoscopic procedures performed annually. In North America overall heavily driven by the U.S. the region accounted for over 38.6% of global market share in 2024. The U.S. alone carries a substantial portion of global procedure volume: in 2024, North America represented 40.9% of global endoscopy procedures, with the U.S. contributing a core share of that volume. Within the U.S., hospitals and ambulatory surgical centers (ASCs) make up the bulk of endoscopy device end-use, reflecting the maturity of healthcare infrastructure and preference for minimally invasive procedures across urban and suburban healthcare settings.

What is Endoscopy Device?

An endoscopy device is a medical instrument used to examine the internal organs and cavities of the human body through minimally invasive procedures. These devices typically consist of a flexible or rigid tube equipped with a camera, light source, and imaging system that allows physicians to diagnose and treat various medical conditions without the need for open surgery. Endoscopy devices are widely used in gastrointestinal, respiratory, urological, gynecological, and surgical procedures due to their ability to provide accurate visualization, faster recovery times, reduced pain, and lower risk of complications for patients.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 60% of global endoscopy procedures now rely on minimally invasive methodologies using endoscopy devices.
• Major Market Restraint: 40% of rural or under-resourced hospitals globally lack access to modern endoscopy equipment (rigid or flexible).
• Emerging Trends: 25% of newly installed endoscopy systems in 2024–2026 feature AI-enabled visualization or video-based enhancements.
• Regional Leadership: North America held 38.6% share of the global endoscopy devices market in 2024.
• Competitive Landscape: The top devices segment (endoscopes) held approximately 37.4%–41.1% share of the global market in 2024.
• Market Segmentation: By end-use, outpatient facilities (clinics and ASCs) accounted for around 53.6% of usage in 2024.
• Recent Development: Single-use endoscopes represented about 22% of new installations globally in 2024–2026.

Latest Trends

The global endoscopy device market in 2024–2026 has been witnessing notable shifts toward advanced technologies, disposable systems, and increased procedural volume. In 2024, the market size was estimated at USD 50.01 billion, underscoring robust baseline demand. Simultaneously, the total number of global endoscopic procedures in 2024 stood at 191.1 million procedures, showcasing widespread application of endoscopy devices across disciplines such as gastroenterology, urology, respiratory/endobronchial, gynecology, and others. Among these, gastrointestinal endoscopy remained predominant, accounting for approximately 69.8% of procedures globally. There is a clear trend toward flexible endoscopes and video-based systems: flexible and video-based endoscopes constitute more than 55% of total installations globally, reflecting a preference for improved flexibility, imaging clarity, and minimally invasive access. The uptake of single-use endoscopes grew significantly in 2024–2026, representing about 22% of new installations worldwide, driven by heightened infection-control requirements and cost-benefit considerations in high-volume hospitals and outpatient centers. Moreover, AI-enabled endoscopic visualization systems are gaining ground: around 25% of newly acquired systems feature AI support for real-time lesion detection, enhancing diagnostic accuracy and procedural efficiency. In the outpatient and ambulatory surgery center (ASC) segment, the share of device usage is increasing relative to traditional hospitals, with outpatient facilities capturing around 53.6% of endoscopy device end-use in 2024. These trends collectively show how the global endoscopy device market is shifting toward flexibility, safety, advanced imaging, and broader procedure settings.

How does AI influence the Endoscopy Device Market?

Artificial Intelligence (AI) is significantly transforming the endoscopy device market by enhancing diagnostic accuracy and improving procedural efficiency. AI-enabled visualization systems can assist healthcare professionals in real-time lesion detection, image analysis, and early disease identification during endoscopic procedures. These advanced technologies help reduce diagnostic errors, improve workflow efficiency, and support faster clinical decision-making. The increasing integration of AI into modern endoscopy systems is driving the adoption of advanced imaging solutions across hospitals, ambulatory surgical centers, and specialty clinics worldwide.

Market Dynamics

DRIVER

"Rising demand for minimally invasive procedures and high procedure volumes"

The primary driver of global endoscopy device adoption is the increasing preference for minimally invasive diagnostic and therapeutic procedures across multiple medical fields. Endoscopy devices allow physicians to visualize internal organs through thin tubes equipped with camera and light, reducing the need for open surgeries and enabling faster recovery, lower risk, and shorter hospital stays. In 2024, global procedures reached 191.1 million, with gastrointestinal endoscopy making up 69.8% of that volume, reflecting massive procedural demand. As chronic diseases especially gastrointestinal disorders, urological conditions, respiratory ailments, and cancers become more prevalent worldwide, the requirement for diagnostic endoscopy and therapeutic interventions rises. Furthermore, demographic shifts such as an aging global population contribute to a higher incidence of conditions that necessitate endoscopic screening or surgery, thereby driving market growth. Advanced imaging and flexible / video-based endoscopes dominate more than 55% of installations globally in the current phase, driven by demand for improved procedure outcomes and patient comfort.

RESTRAINT

"Limited access and resource constraints in under-resourced regions"

Despite growth, a significant restraint remains: many rural, underfunded, or lower-income region hospitals globally estimated around 40% in some analyses lack access to modern endoscopy equipment. These hospitals often lack the trained personnel, sterilization infrastructure, or funding needed to adopt flexible or video-based endoscopy systems. As a result, potential demand in such regions remains unmet. Moreover, reusable endoscopes require rigorous reprocessing, sterilization, and maintenance practices that may not be feasible in resource-limited settings deterring adoption. Such constraints thereby limit the penetration of advanced endoscopy devices in certain markets, dampening overall global device demand growth.

OPPORTUNITY

"Growth in single-use endoscopes and AI-enabled visualization systems"

There is a growing opportunity in disposable or single-use endoscopy devices, which represented roughly 22% of new installations globally in 2024–2026. This trend is driven by concerns around cross-contamination, sterilization overheads, and infection control, especially in high-volume centers. Single-use systems lower the burden of reprocessing and reduce risk of hospital-acquired infections, making them attractive for both developed and emerging markets. Concurrently, AI-enabled endoscopy visualization systems are seeing rising adoption: around 25% of new systems feature AI-based lesion detection and enhanced imaging support as of 2024. For B2B buyers hospital operators, outpatient facility chains, ASCs these innovations signal a valuable opportunity to modernize endoscopy suites, improve diagnostic accuracy, reduce risk, and optimize operational throughput.

CHALLENGE

"High cost of advanced systems and training/infrastructure requirements"

While advanced flexible video-based and AI-enabled endoscopy systems offer clear benefits, their higher acquisition and maintenance costs pose a major challenge, especially for smaller hospitals and clinics in lower-income regions. The need for trained personnel, sterilization and reprocessing facilities, maintenance, and quality assurance further complicates adoption. Additionally, rigid endoscopes and reusable devices require thorough sterilization failure or inefficiency in reprocessing can raise infection risks or regulatory scrutiny. In resource-limited settings, this challenge reduces adoption rates, limiting market penetration despite potential need.

Why is the Endoscopy Device Industry experiencing rapid growth?

The endoscopy device industry is experiencing rapid growth due to the increasing global demand for minimally invasive diagnostic and surgical procedures. Rising prevalence of gastrointestinal disorders, cancers, respiratory diseases, and chronic medical conditions has significantly increased the number of endoscopic procedures worldwide. In addition, advancements in flexible endoscopes, video imaging systems, disposable endoscopes, and AI-assisted technologies are improving patient outcomes and procedural efficiency. Growing awareness regarding early disease detection, combined with expanding healthcare infrastructure and aging populations, is further supporting market expansion globally.

Segmentation Analysis

The global endoscopy device market can be segmented by type and application:

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Flexible Endoscopes: Flexible endoscopes have become the dominant segment globally, thanks to their adaptability across multiple diagnostic and therapeutic procedures. Flexible systems including gastrointestinal scopes, bronchoscopes, urological scopes and other specialty endoscopes are preferred due to their ease of navigation through curved anatomical pathways, enabling minimally invasive access for internal organs. Flexible endoscopes comprise a majority of total installations: in 2024–2026, flexible and video-based systems together represented more than 55% of installations globally. Their growing popularity is further boosted by the need for frequent gastrointestinal endoscopies: in 2024, 69.8% of global endoscopic procedures were gastrointestinal in nature.

Rigid Endoscopes: Rigid endoscopes used in arthroscopy, laparoscopy, urology, ENT, and certain surgical endoscopic procedures continue to hold a stable segment of the market. Their strength lies in surgical precision for procedures requiring mechanical work, such as removal of tissues, lithotripsy in urology, arthroscopy in orthopedics, and laparoscopic interventions. As of early 2020s, the number of hospitals globally has been increasing (for example, over 6,120 hospitals in the U.S. in 2024), leading to rising demand for rigid endoscopes for surgical procedures in hospital settings.

By Application

Hospital & Clinic Settings: Hospitals and clinics remain the backbone end-use segment for endoscopy devices, handling both diagnostic and therapeutic endoscopy procedures. In 2024, hospitals and academic medical centers captured a substantial portion of device usage globally; in many studies, hospitals accounted for approximately 45% to 48% of endoscopy device utilization, reflecting that major invasive diagnostics and surgeries continue to be hospital-based.

Ambulatory Surgical Centers (ASCs) & Outpatient Facilities: Outpatient facilities and ASCs are a growing end-use segment. In 2024, outpatient facilities accounted for around 53.6% of global endoscopy device end-use, reflecting a shift toward outpatient-based minimally invasive diagnostics and therapeutic procedures. The trend toward outpatient use is driven by shorter patient recovery times, lower costs, and rising demand for efficiency, especially in regions with well-developed outpatient care infrastructure (e.g., North America, parts of Europe, some Asia-Pacific hubs).

Others: Other settings including specialty clinics, mobile endoscopy units, diagnostic centers outside traditional hospitals/ASCs also contribute to device utilization, particularly in regions where hospital access is limited. These “other” end-use channels benefit from the introduction of portable, disposable, and lower-cost endoscopy solutions that require minimal infrastructure and can serve remote or underserved populations.

Which segment is expected to witness the fastest growth?

The flexible endoscopes and outpatient facility segments are expected to witness the fastest growth in the endoscopy device market. Flexible and video-based endoscopes are gaining widespread adoption because they offer improved maneuverability, enhanced imaging quality, and greater patient comfort during minimally invasive procedures. At the same time, ambulatory surgical centers (ASCs) and outpatient facilities are rapidly expanding due to shorter recovery times, lower healthcare costs, and increasing preference for same-day procedures. Additionally, single-use endoscopes and AI-enabled systems are emerging as rapidly growing categories within the market.

Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

In 2024, North America held the largest share in the global endoscopy devices market, representing about 38.6% of global market value. The dominance is driven by advanced healthcare infrastructure, high procedure volume, and strong adoption of minimally invasive diagnostics and surgeries. In procedural terms, North America accounted for around 40.9% of global endoscopy procedures in 2024. The U.S. stands at the core of this regional leadership: the large number of GI procedures (colonoscopies, gastroscopies), bronchoscopies and other endoscopic interventions contribute heavily to device demand. Hospitals and ambulatory surgical centers (ASCs) in the U.S. continue to upgrade to flexible and video-based endoscopes with advanced imaging, fueling device turnover. Moreover, single-use endoscopes and AI-enabled visualization systems are increasingly adopted in high-volume institutions, reflecting a shift toward more efficient, safer, and higher-quality endoscopy workflows. This strong foundation supports robust market penetration and high demand per capita compared to other regions.

Europe

Europe holds a significant share of the global endoscopy devices market; various sources indicate that the region accounts for approximately 29% of global endoscopic procedure volume. European demand is supported by well-established healthcare systems, high per-capita medical expenditure, and a rising prevalence of gastrointestinal and chronic diseases requiring endoscopic diagnosis or treatment. Many European countries continue to modernize hospital infrastructure, adopt minimally invasive surgical technologies, and upgrade endoscopy suites with video-based and flexible devices. The strong presence of both private and public hospitals, clinics, and outpatient centers helps maintain steady demand for endoscopy devices. Additionally, growing awareness of preventive health screening (e.g., colorectal cancer screening) drives further procedural volume, underpinning long-term stability and steady expansion in device adoption across Europe.

Asia-Pacific

The Asia-Pacific region is emerging as a major growth hub for endoscopy devices. In 2024, the region accounted for around 21% of global endoscopy procedures volume. The growth is driven by rising healthcare investments, expanding hospital infrastructure, increasing prevalence of chronic gastrointestinal and other diseases, and growing geriatric population. Many countries within Asia-Pacific including large populations in China, India, Japan, and Southeast Asian nations are scaling up their endoscopy capacity, adopting flexible endoscopes, and integrating video-based and modern imaging systems. Flexible endoscopes account for a major portion of device deployments in this region due to their versatility and cost-effectiveness. The region’s share in global market value is rising steadily, reflecting increasing procedure volume and adoption of modern endoscopic technology in both urban and semi-urban healthcare centers.

Middle East & Africa

The Middle East & Africa region currently holds a smaller but growing portion of the global endoscopy devices market. According to certain regional analyses, Middle East & Africa represent around 8% of the global procedure volume. The growth drivers include increasing healthcare infrastructure investments, rising awareness of minimally invasive treatment options, and expansion of private healthcare facilities. In many countries across Middle East & Africa, adoption of flexible and video-based endoscopy devices is gaining traction, though penetration remains lower compared to developed regions due to resource constraints, limited trained personnel, and infrastructure gaps. Nonetheless, rising demand for endoscopic diagnostics and treatments especially for chronic and lifestyle-related diseases is gradually expanding the market share, indicating potential for future growth as healthcare systems mature and investments increase.

Which region holds the largest market share?

North America holds the largest share of the global endoscopy device market due to its advanced healthcare infrastructure, high procedural volume, strong adoption of minimally invasive technologies, and significant healthcare expenditure. The region benefits from the presence of leading medical device manufacturers, widespread availability of advanced hospitals and ambulatory surgical centers, and growing adoption of AI-enabled and single-use endoscopy systems. Increasing awareness regarding preventive healthcare and early diagnosis further strengthens the region’s leadership in the global market.

List of Top Global Companies

• Olympus
• HOYA
• Fujifilm
• Richard Wolf
• Karl Storz
• Stryker
• Braun
• Smith & Nephew
• Henke-Sass
• Medtronic
• Conmed
• ShenDa
• TianSong
• SonoScape
• Aohua
• SMOIF

Top Two Companies with Highest Market Share:

• Olympus Corporation  Olympus remains a leader worldwide in endoscopes and endoscopy systems, with a significant share of the global endoscopy devices market and widespread presence across hospitals and outpatient centers.
• Fujifilm Holdings Corporation  Fujifilm is another dominant player, offering a wide range of endoscopic devices, visualization systems, and flexible scopes, known for quality and innovation, capturing a major portion of global device instal

Investment Analysis and Opportunities

Investment prospects in the global endoscopy devices market are substantial, with multiple promising avenues for stakeholders, suppliers, and healthcare investors. The steady baseline of 191.1 million procedures in 2024 underlines a high recurring demand for endoscopy devices globally, creating a strong recurring consumable and device replacement market. Given that flexible and video-based endoscopes dominate more than 55% of installations and that single-use devices are rising (22% of new installations in 2024–2026), there’s a clear opportunity for investment into manufacturing and supply of disposable endoscopes reducing sterilization burden and addressing infection-control concerns.

Furthermore, the growing adoption of AI-enabled visualization systems (approx. 25% of new installations) presents opportunity for companies to invest in R&D, software platforms, and imaging hardware. Suppliers offering AI-integrated endoscopy devices may capture premium segments of the market, especially in developed regions with high-quality standards. In emerging regions particularly in Asia-Pacific and some Middle East / Africa nations investments in establishing endoscopy suites, outpatient centers, and flexible video-based endoscopy devices can yield long-term returns as healthcare infrastructure expands and chronic disease burden rises.

Another investment angle lies in training and reprocessing infrastructure: setting up sterilization, maintenance, and service networks in underserved regions can improve device adoption and retention. Given that many rural or resource-limited hospitals currently lack modern endoscopy devices (estimated ~40%), investments in supporting infrastructure can unlock untapped markets, enabling device suppliers to expand reach. For B2B investors, joint ventures or partnerships with local healthcare providers, outpatient surgery centers, or public-private healthcare expansion projects in emerging markets may offer long-term growth potential.

New Product Development

In recent years, the market has seen accelerated innovation and product development across endoscopy devices, focusing on improved imaging, safety, disposability, and procedural efficiency. For instance, flexible video-based endoscopes and AI-enabled visualization systems now represent a significant portion of installations globally over 55% of total endoscopy installations in 2024–2026 are flexible/video systems.

Single-use endoscopes have emerged as a key product category: in 2024–2026, about 22% of new installations globally were single-use devices. These devices reduce infection risk, eliminate reprocessing needs, and simplify logistics features appealing to high-volume hospitals, outpatient centers, and emerging markets with limited sterilization infrastructure.

Simultaneously, AI-enabled platforms integrated into endoscopy visualization systems are redefining diagnostics: roughly 25% of new devices acquired in 2024–2026 incorporated AI-based real-time lesion detection and enhanced imaging, improving diagnostic accuracy and supporting early detection workflows.

Moreover, manufacturers are expanding device comfort and versatility offering flexible endoscopes suitable for GI, urological, ENT, and respiratory applications thereby increasing utilization across multiple disciplines and maximizing value per installed device. This multi-purpose capability, along with modular systems for visualization, recording, and accessory integration, drives equipment upgrades and replacements globally.

These developments reflect how the market is shifting from traditional reusable rigid scopes toward a hybrid ecosystem of flexible, disposable, video-based, AI-enabled, and multi-disciplinary systems, optimized for modern clinical workflows, infection control, and broad procedural coverage.

Five Recent Developments (2023–2026)

• In 2024, global market research reported that flexible and video-based endoscopes (over 55% of total installations globally) now dominate new device installations, reflecting a shift from rigid to flexible systems.
• As of 2024–2026, single-use endoscopes accounted for approximately 22% of new installations globally, indicating rising adoption driven by infection-control concerns and ease of deployment.
• AI-enabled endoscopic visualization systems have penetrated about 25% of new acquisitions by hospitals and ASCs worldwide in 2024–2026, improving real-time lesion detection and diagnostic workflows.
• In 2024, total global endoscopic procedures reached 191.1 million, with gastrointestinal endoscopy constituting 69.8% of this volume the highest among all applications.
• Regional shares shifted: North America maintained leadership with ≈ 38.6% of global market value in 2024, while Asia-Pacific recorded rapid growth in device adoption and procedure volume, signaling shifting regional dynamics.

Report Coverage

The scope of this market report “Endoscopy Device Market Report / Endoscopy Device Market Analysis / Endoscopy Device Market Insights / Endoscopy Device Market Size / Endoscopy Device Market Forecast” covers a comprehensive range of dimensions. It examines the market by product type (endoscopes, visualization systems, operative devices, components), by type (rigid endoscopes, flexible endoscopes, video/fiber endoscopes, single-use endoscopes), by application (gastrointestinal endoscopy, urology, laparoscopy, gynecology, ENT, bronchoscopy, arthroscopy, others), by end-use setting (hospitals and clinics, ambulatory surgical centers and outpatient facilities, others), and by region (North America, Europe, Asia-Pacific, Middle East & Africa, others). It further incorporates procedural data e.g., global procedures volume (191.1 million in 2024), distribution by application (GI 69.8%), and regional procedural shares, to correlate device demand with actual use cases. It analyzes emerging trends such as adoption of flexible and video-based systems, single-use devices, AI-enabled visualization, shifting end-use settings (rise of outpatient/ASC), and regional growth trajectories. The report also covers competitive landscape profiling identifying leading companies by market share, technology offerings, and regional presence. Additionally, there is coverage of recent product developments, technological innovations, and investment and market opportunity analysis, making it a comprehensive resource for stakeholders, manufacturers, healthcare providers, and investors seeking to understand global market dynamics and opportunities in the endoscopy device industry.

Endoscopy Device Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 8362.32 Million in 2026
Market Size Value By	USD 14020.79 Million by 2035
Growth Rate	CAGR of 5.8% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Rigid Endoscopes Flexible Endoscopes By Application : Hospital & Clinic ASCs Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample